CURE vs. BTAL

Last updated Jun 13, 2026

CURE (Direxion Daily Healthcare Bull 3x Shares) and BTAL (AGFiQ US Market Neutral Anti-Beta Fund) are both exchange-traded funds - CURE is a Leveraged Equities fund tracking the Health Care Select Sector Index (300%), while BTAL is a Long-Short fund tracking the Dow Jones U.S. Thematic Market Neutral Anti-Beta Total Return Index. Both are passively managed. Over the past 10 years, CURE returned 13.49%/yr vs -5.05%/yr for BTAL. At a correlation of -0.26, they often move in opposite directions. CURE charges 1.08%/yr vs 2.11%/yr for BTAL.

Performance

CURE vs. BTAL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily Healthcare Bull 3x Shares (CURE) and AGFiQ US Market Neutral Anti-Beta Fund (BTAL). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CURE achieves a -7.96% return, which is significantly higher than BTAL's -20.15% return. Over the past 10 years, CURE has outperformed BTAL with an annualized return of 13.49%, while BTAL has yielded a comparatively lower -5.05% annualized return.

CURE

• 1D: -0.55%
• 1M: 13.53%
• YTD: -7.96%
• 6M: -6.00%
• 1Y: 26.46%
• 3Y*: 3.05%
• 5Y*: 1.51%
• 10Y*: 13.49%

BTAL

• 1D: -0.09%
• 1M: -4.33%
• YTD: -20.15%
• 6M: -19.27%
• 1Y: -36.60%
• 3Y*: -12.17%
• 5Y*: -4.94%
• 10Y*: -5.05%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CURE vs. BTAL - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CURE Direxion Daily Healthcare Bull 3x Shares	-7.96%	22.55%	-8.47%	-9.40%	-20.51%	88.30%	5.02%	55.66%	2.82%	69.32%
BTAL AGFiQ US Market Neutral Anti-Beta Fund	-20.15%	-20.17%	12.83%	-15.11%	20.48%	-6.81%	-13.86%	1.07%	15.13%	-2.13%

Correlation

The correlation between CURE and BTAL is -0.11, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.11
Correlation (3Y) Calculated over the trailing 3-year period	-0.13
Correlation (5Y) Calculated over the trailing 5-year period	-0.20
Correlation (10Y) Calculated over the trailing 10-year period	-0.23
Correlation (All Time) Calculated using the full available price history since Sep 13, 2011	-0.26

The correlation between CURE and BTAL shifts across timeframes, from -0.26 (all time) to -0.11 (1 year), reflecting how their relationship changes across market environments.

CURE vs. BTAL - Sectors Allocation Comparison

Sectors	CURE	BTAL
Healthcare	100.0%	10.2%
Basic Materials	-	4.0%
Communication Services	-	3.4%
Consumer Cyclical	-	12.8%
Consumer Defensive	-	5.6%
Energy	-	4.4%
Financial Services	-	14.9%
Industrials	-	13.7%
Real Estate	-	6.2%
Technology	-	19.5%
Utilities	-	5.2%

Return for Risk

CURE vs. BTAL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CURE

CURE Risk / Return Rank: 21
CURE Sharpe Ratio Rank: 20
CURE Sortino Ratio Rank: 24
CURE Omega Ratio Rank: 22
CURE Calmar Ratio Rank: 22
CURE Martin Ratio Rank: 19

BTAL

BTAL Risk / Return Rank: 0
BTAL Sharpe Ratio Rank: 0
BTAL Sortino Ratio Rank: 0
BTAL Omega Ratio Rank: 0
BTAL Calmar Ratio Rank: 0
BTAL Martin Ratio Rank: 1

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CURE vs. BTAL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and AGFiQ US Market Neutral Anti-Beta Fund (BTAL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	CURE	BTAL	Difference
Sharpe ratio: Return per unit of total volatility	0.60	-1.64	+2.24
Sortino ratio: Return per unit of downside risk	1.18	-2.56	+3.74
Omega ratio: Gain probability vs. loss probability	1.13	0.73	+0.40
Calmar ratio: Return relative to maximum drawdown	0.85	-0.98	+1.83
Martin ratio: Return relative to average drawdown	1.94	-1.64	+3.58

CURE vs. BTAL - Sharpe Ratio Comparison

The current CURE Sharpe Ratio is 0.60, which is higher than the BTAL Sharpe Ratio of -1.64. The chart below compares the historical Sharpe Ratios of CURE and BTAL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

CURE vs. BTAL - Drawdown Comparison

The maximum CURE drawdown since its inception was -69.19%, which is greater than BTAL's maximum drawdown of -50.28%. Use the drawdown chart below to compare losses from any high point for CURE and BTAL.

Drawdown Indicators

	CURE	BTAL	Difference
Max Drawdown Largest peak-to-trough decline	-69.19%	-50.28%	-18.91%
Max Drawdown (1Y) Largest decline over 1 year	-31.10%	-37.50%	+6.40%
Max Drawdown (3Y) Largest decline over 3 years	-51.93%	-45.16%	-6.77%
Max Drawdown (5Y) Largest decline over 5 years	-52.23%	-45.16%	-7.07%
Max Drawdown (10Y) Largest decline over 10 years	-69.19%	-50.28%	-18.91%
Current Drawdown Current decline from peak	-26.94%	-50.23%	+23.29%
Average Drawdown Average peak-to-trough decline	-18.16%	-22.01%	+3.85%
Ulcer Index Depth and duration of drawdowns from previous peaks	13.71%	22.38%	-8.67%

Volatility

CURE vs. BTAL - Volatility Comparison

Direxion Daily Healthcare Bull 3x Shares (CURE) has a higher volatility of 14.30% compared to AGFiQ US Market Neutral Anti-Beta Fund (BTAL) at 8.74%. This indicates that CURE's price experiences larger fluctuations and is considered to be riskier than BTAL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CURE	BTAL	Difference
Volatility (1M) Calculated over the trailing 1-month period	14.30%	8.74%	+5.56%
Volatility (6M) Calculated over the trailing 6-month period	30.87%	16.58%	+14.29%
Volatility (1Y) Calculated over the trailing 1-year period	44.32%	22.49%	+21.83%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	43.84%	18.96%	+24.88%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	49.59%	17.33%	+32.26%

CURE vs. BTAL - Expense Ratio Comparison

CURE has a 1.08% expense ratio, which is lower than BTAL's 2.11% expense ratio.

Dividends

CURE vs. BTAL - Dividend Comparison

CURE's dividend yield for the trailing twelve months is around 1.16%, less than BTAL's 3.11% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017
BTAL AGFiQ US Market Neutral Anti-Beta Fund	3.11%	2.49%	3.49%	6.14%	1.01%	0.00%	0.00%	0.88%	0.39%	0.00%
CURE Direxion Daily Healthcare Bull 3x Shares	1.16%	1.12%	1.17%	2.02%	0.38%	0.02%	0.17%	0.40%	0.70%	0.18%

Frequently Asked Questions

Can I hold both CURE and BTAL in my portfolio?

CURE and BTAL have a correlation of -0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CURE or BTAL?

CURE has higher volatility (14.30%) compared to BTAL (8.74%). In terms of maximum drawdown, CURE dropped -69.19% vs BTAL's -50.28%.

Which ETF is better, CURE or BTAL?

On 10-year performance, CURE leads with 13.49% vs -5.05% for BTAL. On fees, CURE is cheaper at 1.08% per year. On volatility, BTAL has been the lower-risk option at 8.74%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, CURE or BTAL?

Over the 10-year period, CURE has performed better with a 13.49% return vs -5.05%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, CURE or BTAL?

CURE is cheaper with a 1.08% expense ratio, compared with 2.11% for BTAL.

Which ETF pays a higher dividend yield, CURE or BTAL?

BTAL has the higher dividend yield at 3.11%, compared with 1.16% for CURE.

What is the main difference between CURE and BTAL?

CURE is categorized as Leveraged Equities, while BTAL is Long-Short. CURE tracks Health Care Select Sector Index (300%), while BTAL tracks Dow Jones U.S. Thematic Market Neutral Anti-Beta Total Return Index. They also come from different issuers: Direxion and AGF. Their fees differ too: 1.08% for CURE and 2.11% for BTAL.

Which has better risk-adjusted returns?

CURE currently has the higher Sharpe Ratio (0.60 vs -1.64), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.